Media Requests
Please send all media-related inquiries and interview requests to mediarelations@lls.org.
An LLS representative will respond as soon as possible.
Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company
For Immediate Release
Contact: Andrea Greif
Senior Director of Communications
(914)821-8958 (p)
914)772-3027 (c)
andrea.greif@lls.org
White Plains, NY - March 30, 2015 - A promising University of Michigan research project focused on developing new treatments for patients with a rare and lethal subtype of leukemia has received a significant boost from a recent licensing agreement ...
Extraordinary Individuals Are Saving Lives Not Someday, But Today
Contact: Kristin Hoose
(914) 821-8973
kristin.hoose@lls.org
White Plains, NY (March 16, 2015) - For 10 weeks, in more than 80 cities across the country, 900 dedicated fundraising participants are competing on a local and national level to help the more than one million Americans who are living with or in remission from a blood cancer. Today, The Leukemia & Lymphoma Society (LLS) is celebr...
Study Commissioned by The Leukemia & Lymphoma Society Shows Benefits of Limiting Out-of-Pocket Costs for Patients Purchasing Prescription Drugs
For Immediate Release
Contact: Andrea Greif
Senior Director of Communications
(914)821-8958 (p)
914)772-3027 (c)
andrea.greif@lls.org
(White Plains, NY) - March 9, 2015 - A new study finds that capping the cost-sharing for prescription drugs on individual policies in the health insurance marketplace would reduce patients' annual out-of-pocket healthcare spending, and have...
The Leukemia & Lymphoma Society Applauds Therapy Advances for Myeloma Patients
For Immediate Release
Contact: Andrea Greif
Senior Director of Communications
(914)821-8958 (p)
914)772-3027 (c)
andrea.greif@lls.org
(White Plains, NY) - February 26, 2015 - Two recent approvals by the U.S. Food and Drug Administration (FDA) will provide significant additional options for myeloma patients, both newly diagnosed and previously treated.
Myeloma is a relati...
LLS Announces Recipients of Quest for Cures Grant Program
Contact: Andrea Greif
(914) 821-8958
andrea.greif@lls.org
White Plains, NY (January 23, 2014) - The Leukemia & Lymphoma Society (LLS) today is pleased to announce the14 researchers who will receive funding through the Quest for Cures program - a new grant program that addresses three critical areas of blood cancer research.
The three priority areas are: monitoring tumor cell heterogeneity...
LLS Announces Recipients of The New Idea Award Grant Program
Contact: Andrea Greif
(914) 821-8958
andrea.greif@lls.org
White Plains, NY (October 22, 2013) - The Leukemia & Lymphoma Society (LLS) today is pleased to announce the researchers who will receive The New Idea Award - a grant program designed to identify novel research strategies with high potential for significant impact on the future of blood cancer treatments.
Specifically, this program supp...
LLS Awards Four Major Grants to Acclaimed Researchers
White Plains, NY (October 15, 2013) - The Leukemia & Lymphoma Society (LLS) today announced it has awarded four new grants through its prestigious Marshall A. Lichtman Specialized Center of Research (SCOR) research initiative, bringing the program's total funding to $285 million since its inception in 2000. The innovative SCOR program funds teams of researchers representing different disciplines and engag...
Narrow Networks and High Cost-Sharing Among Concerns Raised by New Report on Affordable Care Act
Contact: Andrea Greif (914) 821-8958
andrea.greif@lls.org
White Plains, NY (Jan. 15, 2014) - Many qualified health plans participating in the new insurance exchanges have limited access to National Cancer Institute (NCI) designated cancer or transplant centers, and would impose high out-of-pocket costs for patients purchasing at the silver and bronze levels, according to a report commissioned by The Leukemi...